These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1551218)

  • 1. Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic.
    Vanerio G; Maloney JD
    Cleve Clin J Med; 1992; 59(1):79-86. PubMed ID: 1551218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moricizine hydrochloride (Ethmozine).
    Dunn SL
    Crit Care Nurse; 1992 Apr; 12(4):61-3. PubMed ID: 1568380
    [No Abstract]   [Full Text] [Related]  

  • 4. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placement of moricizine in the selection of antiarrhythmic drug therapy.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
    Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
    Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moricizine: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP
    Am J Med Sci; 1991 Jun; 301(6):398-401. PubMed ID: 2039027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
    Damle R; Levine J; Matos J; Greenberg S; Brooks R; Frumkin W; Goldberger J; Kadish AH
    Ann Intern Med; 1992 Mar; 116(5):375-81. PubMed ID: 1736770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moricizine (ethmozine HCl)--a new antiarrhythmic drug: is it unique?
    Podrid PJ
    Am J Cardiol; 1991 Dec; 68(15):1521-5. PubMed ID: 1746437
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of moricizine in malignant ventricular arrhythmias.
    Horowitz LN
    Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: insights into mechanism of action.
    Wechsler ME; Steinberg JS; Giardina EG
    J Am Coll Cardiol; 1991 Jun; 17(7):1626-33. PubMed ID: 1709654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: documentation of efficacy and long-term safety.
    Pratt CM; Yepsen SC; Taylor AA; Mason DT; Miller RR; Quinones MA; Lewis RA
    Am Heart J; 1983 Jul; 106(1 Pt 1):85-91. PubMed ID: 6346845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
    Giardina EG; Wechsler ME; Dolgopiatova M; Sciacca R
    J Clin Pharmacol; 1994 Jul; 34(7):725-33. PubMed ID: 7523457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (Ethmozine) in patients resistant to conventional antiarrhythmics.
    Pratt CM; Young JB; Wierman AM; Borland RM; Seals AA; Leon CA; Raizner A; Quinones MA; Roberts R
    Am J Med; 1986 Apr; 80(4):626-32. PubMed ID: 3515932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.